Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
11/2003
11/20/2003US20030216418 Novel compositions comprising trimetrexate and methods of their synthesis and use
11/20/2003US20030216417 Substituted anilino-quinoline compounds and use thereof
11/20/2003US20030216406 Pyrimidine derivatives
11/20/2003US20030216404 Hydroxamic acid derivatives
11/20/2003US20030216402 Administering to the living body a oxo-azabicyclo derivative to treat disease selected from arthritis, osteoporosis, periodontal diseases, inflammatory bowel disease, psoriasis, multiple sclerosis, asthma, cancer and macular degeneration
11/20/2003US20030216382 Useful for the treatment and/or prophylaxis of diseases associated with dipeptidyl peptidase, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance
11/20/2003CA2485148A1 Pyrimidinone compounds, compositions and methods
11/19/2003EP1362839A2 Liquid crystal composition having a delta-epsilon- of not less than zero and liquid crystal display device
11/19/2003EP1362041A1 Aryl carbamate derivatives, preparation and use thereof
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP1361899A2 Devices and methods for the treatment of cancer
11/19/2003EP1361879A1 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators
11/19/2003EP1361873A2 Matrix metalloproteinase inhibitors
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0852226B1 Pyrimidine derivatives
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/18/2003US6649797 Contacting protein with a compound that is capable of stable reversible binding with basic amino acid residues of nuclear localization signal of protein for inactivating a nuclear localization signal of a protein
11/18/2003US6649760 Substituted phenyluracils
11/18/2003US6649691 Wet adhesion monomer and derived copolymers for latex paints
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
11/18/2003US6649622 Treating diabetes, especially Type II diabetes
11/18/2003US6649620 Quinoline and quinazoline compounds useful in therapy
11/18/2003US6649619 Compounds
11/18/2003US6649618 Substituted amidoalkyl-uracils and their use
11/18/2003US6649608 Cyclin-dependent serine/threonine and focal adhesion kinase inhibitors
11/18/2003US6649604 Analgesics; antidiabetic agents; antiinflamamtory agents
11/18/2003CA2072233C Triazolopyrimidine derivatives which are angiotensin ii receptor antagonists; processes for preparing them and pharmaceutical compositions containing them
11/13/2003WO2003093371A1 Water-soluble fiber-reactive dyes, method for the production and use thereof
11/13/2003WO2003093244A1 Substituted (thioxo)carbonylamino phenyl uraciles
11/13/2003WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/13/2003WO2003092697A1 Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
11/13/2003WO2003092686A1 Inhibitors of histone deacetylase
11/13/2003WO2003092670A1 Bombesin antagonists
11/13/2003WO2003092374A2 Pesticidal heterocycles
11/13/2003WO2003076417A3 Oxo-azabicyclic compounds
11/13/2003WO2003029200A3 Compounds useful as reversible inhibitors of cysteine proteases
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2002032874A8 Substituted heterocyclic compounds for treating multidrug resistance
11/13/2003WO2002032868A8 2-substituted heterocyclic compounds and their use in treating multidrug resistance
11/13/2003US20030212269 Kinase inhibitor; antitumor agents, psoriasis, skin disorders, antiarthritic agents
11/13/2003US20030212140 Analgesics; central nervous system disorders
11/13/2003US20030212116 Contorlling plant disease
11/13/2003US20030212081 Bicyclic heteroaromatic compounds useful as LH agonists
11/13/2003US20030212079 Antiischemic agents; central nervous system disorders
11/13/2003US20030212068 Antiinflammatory agents; antiallergens; antiarthritic agents
11/13/2003US20030211079 Immobilization with polyoxyethylene glycol; adjust circulation half-life
11/13/2003US20030209243 Dry powder dispersing apparatus and methods for their use
11/13/2003US20030209166 Ink composition containing a particular type of dye, and corresponding ink jet printing process
11/13/2003CA2484582A1 Bombesin antagonists
11/13/2003CA2484280A1 Substituted (thioxo)carbonylamino phenyl uraciles
11/13/2003CA2484065A1 Inhibitors of histone deacetylase
11/13/2003CA2483933A1 Water-soluble fiber-reactive dyes, preparation thereof and use thereof
11/13/2003CA2462645A1 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/12/2003EP1361227A2 [5-carboxamide or 5-fluoro]-[2', 3'-unsaturated or 3'-modifield]-pyrimidine nucleosides
11/12/2003EP1361218A1 Trifluoromethanesulfonyl anilide derivatives, process for the preparation of them and herbicides containing them as the active ingredient
11/12/2003EP1282614B1 Hydroxamic acid derivatives
11/12/2003EP1206444B1 Compounds that inhibit tryptase activity
11/12/2003EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors
11/12/2003EP1037881B1 Process of preparing substituted pyrimidinones
11/12/2003EP0752987B1 Pyrimidinyl derivatives as interleukin inhibitors
11/11/2003US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/11/2003US6645991 αvβ3 integrin inhibitors
11/11/2003US6645969 Antiproliferative, anticarcinogenic, and antiinflammatory agents; treatment of leukemia, psoriasis, bone disorders, and atherosclerosis
11/11/2003US6645968 Potassium channel openers
11/11/2003US6645965 Nitrate salts of antihypertensive medicines
11/11/2003US6645958 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
11/11/2003CA2264745C Method of inhibiting biosynthesis of eif5a
11/11/2003CA2133579C Synergistic composition and process for selective weed control
11/11/2003CA2113424C Muscarinic agonists
11/06/2003WO2003091675A2 Ultrasonic doppler effect speed measurement
11/06/2003WO2003091264A2 Non nucleoside reverse transcriptase inhibitors
11/06/2003WO2003091232A2 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
11/06/2003WO2003091224A1 Quinazoline derivative and medicine
11/06/2003WO2003091223A1 Pyrimidine derivative
11/06/2003WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient
11/06/2003WO2003090691A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003WO2003090690A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/06/2003WO2003039539A3 Use of endothelin receptor antagonists in the treatment of tumour diseases
11/06/2003WO2002094799A3 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/06/2003US20030208087 Sulfur compounds such as methyl 2-amino-4-methanesulfonylamino methylbenzoate, used as herbicides
11/06/2003US20030208067 Inhibitors of protein kinase for the treatment of disease
11/06/2003US20030207919 For treating, preventing, reducing inflammation, pain, fever,gastrointestinal disorders; decreasing gastrointestinal, renal and other toxicities resulting from use of nonsteroidal antiinflammatory drugs; multiplicity of compounds
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/06/2003US20030207882 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
11/06/2003US20030207877 Pyridoquinoxaline antivirals
11/06/2003US20030207824 Pyrimidine derivatives for labeled binding partners
11/06/2003US20030207248 Across biological membranes of living cells; screening test chemicals that modulate a target ion channel; using fluorescence resonance energy transfer (FRET)
11/06/2003CA2483530A1 Quinazoline derivatives and medicaments
11/06/2003CA2483155A1 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
11/06/2003CA2481449A1 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003CA2481285A1 Non nucleoside reverse transcriptase inhibitors
11/06/2003CA2454612A1 Ultrasonic doppler effect speed measurement
11/05/2003EP1358909A1 Heteroaryl-phenyl derivatives as factor xa inhibitors for use as antithrombotic and anticoagulant agents
11/05/2003EP1358181A1 Substituted pyrrolidines as ccr-3 receptor antagonists
11/05/2003EP1357905A2 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
11/05/2003EP1357889A1 Novels couplers for use in oxidative hair dyeing
11/05/2003EP1268480B1 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
11/05/2003EP0989985B1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors
11/05/2003CN1454210A 嘧啶衍生物 Pyrimidine derivatives
1 ... 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 ... 427